Johnson & Johnson proposes $8.9bn talc settlement

Johnson & Johnson has proposed an $8.9bn settlement to resolve tens of hundreds of lawsuits alleging its talcum powder brought about most cancers, in an try and resolve long-running litigation that has weighed on the healthcare merchandise firm.

The proposed deal follows a decade-long authorized battle between plaintiffs’ legal professionals and J&J. If permitted, it might turn into the most important product legal responsibility settlement in chapter historical past, in response to legal professionals concerned within the case.

It follows an appeals court docket ruling in January that shot down J&J’s try and implement a fancy chapter scheme known as the “Texas-two step” to handle the talc claims. Beneath this technique J&J had created a $2bn fund to compensate victims.

LTL, the unit created by J&J to accommodate the talc claims, would as soon as once more file for chapter with the intention to facilitate the settlement, the corporate mentioned.

J&J mentioned it continued to imagine the claims had been “specious and lack scientific benefit” and the settlement was not an admission of wrongdoing. Nevertheless it mentioned resolving the instances within the civil court docket system would take a long time and impose important prices on the corporate.

“Resolving this matter via the proposed reorganisation plan is each extra equitable and extra environment friendly, permits claimants to be compensated in a well timed method, and permits the corporate to stay centered on our dedication to profoundly and positively impression well being for humanity,” Erik Haas, J&J’s worldwide vice-president of litigation, mentioned in an announcement.

The draft deal might draw a line underneath one of the crucial bitterly fought product legal responsibility fits in US historical past, involving tens of hundreds of customers of J&J’s child talc who allege it cased their cancers.

A couple of dozen legislation companies representing about 70,000 claimants mentioned they supported the draft deal and had been assured it might safe enough help to win approval within the chapter court docket.

“This settlement is a testomony to the tens of hundreds of girls who’ve battled each most cancers and the court docket system to realize justice for themselves,” mentioned Alicia O’Neill of Watts Guerra, one of many companies representing plaintiffs. “These sturdy girls have ensured that no different girl can be uncovered to this pointless hazard. They deserve compensation and closure.” 

Carl Tobias, professor of legislation at College of Richmond, mentioned J&J’s technique of utilizing the Chapter 11 once more to attempt to resolve the instances via a worldwide settlement appeared dangerous given the decisive dismissal of its earlier chapter by the appeals court docket.

Jon Ruckdeschel, a trial lawyer who has been representing victims of mesothelioma for greater than 20 years, mentioned he was sceptical of J&J’s technique to re-file for chapter. He represents talc plaintiffs, however mentioned he has not but determined to just accept the most recent supply.

“Neither Johnson & Johnson, nor any of its subsidiaries are in any monetary misery. I’m assured that the courts will shortly and assertively reject this newest dangerous religion manipulation of the chapter courts,” he mentioned.

Back To Top